We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Single Chest X-Ray Predicts Mortality Risk

By MedImaging International staff writers
Posted on 08 Aug 2019
Print article
A new study suggests that a convolutional neural network (CNN) can stratify all-cause mortality risk based on a single chest radiograph.

Developed at Massachusetts General Hospital (MGH; Boston, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions, the CNN algorithm, named CXR-risk, uses data from radiologists' diagnostic findings (such as presence of a lung nodule) on a chest x-ray, and combines it with other risk factors, including age, sex and comorbidities in order to predict long-term mortality, including non-cancer death. A deep learning CXR-risk score (very low, low, moderate, high, and very high) is generated based on CNN analysis of a submitted radiograph.

To develop the CNN, the researchers used 41,856 x-rays from the screening radiography arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, a community cohort of asymptomatic nonsmokers and smokers enrolled at 10 U.S. sites from November 8, 1993, through July 2, 2001. The results of the CNN were tested in a further 10,464 cases from the screening radiography arm of the National Lung Screening Trial (NLST), a community cohort of heavy smokers enrolled at 21 U.S. sites from August 2002 through April 2004.

The results revealed a graded association between CXR-risk score and mortality. The very high-risk group had an all-cause mortality of 53% (PLCO) and 33.9% (NLST), compared with the very low-risk group. The association was robust to adjustment for radiologists’ findings and risk factors. Comparable results were seen for lung cancer death, non-cancer cardiovascular death, and respiratory death. The study was published on July 19, 2019, in JAMA Network Open.

“We get chest x-rays to make a diagnosis like pneumonia, but our study shows that there is also free prognostic information about health and longevity on the images. Based on the chest x-ray image alone, AI identified people at up to a 53% risk of death over 12 years,” said lead author Michael Lu, MD, MPH, of MGH and HMS. “Scores calculated using AI may incentivize high-risk individuals to lower their chance of dying with prevention, regular screening, and lifestyle modification.”

Deep learning is part of a broader family of AI machine learning methods based on learning data representations, as opposed to task specific algorithms. It involves CNN algorithms that use a cascade of many layers of nonlinear processing units for feature extraction, conversion and transformation, with each successive layer using the output from the previous layer as input to form a hierarchical representation.

Related Links:
Massachusetts General Hospital
Harvard Medical School

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
Portable X-Ray Unit
AJEX240H

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.